Background {#sec1}
==========

Exercise-based cardiac rehabilitation is well established for achieving better clinical outcomes among patients after AMI (Acute myocardial infarction) and CHF (Congestive heart failure).[@bib1], [@bib2], [@bib3] System-based approach to referral of appropriate patients to rehabilitation programs is advocated,[@bib4] i.e. appropriate patient selection, could potentially increase the yield of such rehabilitation programs.

Frailty assessment is an important step in such patients\' selection process: it is known that patients who are deemed frail, experience worse outcomes after cardiac surgery.[@bib5], [@bib6] Nevertheless, frail elderlies suffering from CVD (Cardiovascular disease) may benefit more from patient-centered, multi-disciplinary programs of cardiac rehabilitation.[@bib7] Therefore, frailty assessment tools, preferably objective and simplified, should be sought.[@bib8]

Low ALT (alanine aminotransferase) activity levels in the peripheral blood have been shown to be associated with lower total-body muscle mass, increased frailty and risk of mortality in elderlies[@bib9] and increased risk of all-cause mortality in both healthy, middle-aged people[@bib10], [@bib11] and patients suffering from stable IHD (Ischemic heart disease).[@bib12] No previous study addressed the potential value of low ALT as a potential predictor for cardiovascular fitness.

In the current study we tried to assess whether low ALT blood activity, as a biomarker for increased frailty, is associated with lower baseline fitness of post-AMI and post-cardiac surgery patients going through a cardiac rehabilitation program.

Patients and methods {#sec2}
====================

Study population {#sec2.1}
----------------

This was a retrospective study in a population of post-AMI and post-cardiac surgery patients participating in a comprehensive cardiac rehabilitation program in a tertiary hospital. Patients with ALT \>40 IU (assumed to have some sort of hepatitis) were excluded as were patients with diagnosis of liver dysfunction or cirrhosis. We further excluded subjects unable to exercise due to cognitive impairment, severe neurological or orthopedic limitations and severe comorbidities with life expectancy \<3 months duration.

Clinical information and laboratory assessment {#sec2.2}
----------------------------------------------

All the subjects underwent blood testing including ALT activity routinely during their hospital stay. In case of multiple tests, we selected the latest lab test for the current analysis. Activity of ALT was assessed using a standardized Beckman Coulter^®^ test. Quantitative determination of ALT levels was used by applying kinetic UV tests. In order to assure maximal catalytic activity of the ALT from the blood drawn, all test tubes were routinely supplemented with activated pyridoxal phosphate (P-5-P), serving as an essential co-factor for ALT catalytic activity.

Outcomes and definitions {#sec2.3}
------------------------

The primary study endpoint was exercise capacity as assessed by graded exercise stress test and expressed in metabolic equivalents of task (METs) estimated according to widely used American collage of Sport Medicine (ACSM) formula.[@bib13] All study subjects underwent a symptom limited stress test within a month prior to cardiac rehabilitation start. Stress tests were supervised by senior cardiologists using the Bruce (69%) or modified Bruce (31%) protocols without withholding cardiac medications. Appropriate stress test protocol was selected by experienced physicians based on patients\' daily activity and reported physical activity. Stress test was limited by symptoms, target heart rate achieved or the appearance of significant ST changes, arrhythmia or other guideline test termination indications.

Statistical analysis {#sec2.4}
--------------------

The study population was divided into two groups based on the ALT levels obtained during the baseline visit of the rehabilitation program. We used a cutoff value of 17 IU/l for defining a group of Low-normal ALT activity, relying on the relevant literature.[@bib10], [@bib11], [@bib12] We compared the lower ALT group (ALT \< 17 IU/l) to the ALT ≥ 17 IU/l group. Blood hemoglobin concentration and Creatinine concentration (needed for eGFR \[estimation of Glomerular Filtration Rate\] were also recorded).

Comparison of categorical variables was performed with chi-square analysis, and comparison of continuous variables was performed with the Student\'s t-test for variables with normal distribution and by the Mann-Whitney test for those that violated the normality assumption.

In order to establish independent predictors of low-normal ALT value, we performed multivariate logistic regression modeling introducing the following covariates: age, gender, Body Mass Index (BMI), diagnosis of diabetes, hypertension, active smoking, dyslipidemia, Chronic Obstructive Pulmonary Disease (COPD), cardiomyopathy, current atrial fibrillation or flutter, past stroke, Left-Ventricular Ejection Fraction (LVEF) \< 50%, prior Myocardial Infarct (MI) or past cardiac valve or coronary bypass surgery (CABG).

In order to assess the independent association of low ALT values and reduced exercise capacity, as assessed by symptom limited exercise stress, we explored the adjusted linear association of METS as a continuous covariate with pretest ALT values.

Covariates which were found to have statistically significant correlation with Mets\' results in the univariate analysis (necessitating level of significance (p) lower than 0.01) were included in the above described multivariate analysis. Thus, multivariate linear model was further adjusted for age, gender, LVEF % (as continuous covariate), hemoglobin level (g/dL) and prior diagnosis of COPD or heart failure.

All statistical tests were two-sided, and a p value of less than 0.05 was considered to indicate statistical significance. Analyses were carried out with the use of SPSS software, version 22 (IBM Inc.) and SAS, version 9.3.

Results {#sec3}
=======

Baseline characteristics were available for 3806 patients ([Table 1](#tbl1){ref-type="table"}). Amongst patients with lower ALT activity at initiation of the rehabilitation program there was a larger proportion of female gender, Diabetes Mellitus, COPD and arterial hypertension. Baseline systolic function, measured as LVEF was not significantly different between participants with low-normal and normal ALT activity and consequently, NYHA (New York Heart Association) functional status, was also not significantly different between these two groups. Essential medications used for the treatment of heart disease were also similar in both study groups.Table 1Baseline characteristics of the whole study cohort.Table 1P valueALT ≥17 IUALT \<17 IUN24701336Patients demographicsNS6164Age (years, mean)P \< 0.001474 (19.2%)402 (30.1%)Female \[n (%)\]0.0627.2 ± 427.8 ± 4BMI (±SD)Background diagnosisP \< 0.05667 (27%)422 (31.6%)Diabetes Mellitus \[n (%)\]P \< 0.0011833 (74.2%)900 (67.4%)IHDP \< 0.0011803 (73%)935 (70%)Past MIP = 0.00173 (3.0%)70 (5.2%)COPDP \< 0.051233 (49.9%)727 (54.4%)HypertensionP = 0.052311 (12.6%)199 (14.9%)CHFP = 0.3241325 (53.6%)694 (51.9%)DyslipidemiaP = 0.09174 (3.0%)54 (4.0%)PVDP = 1208 (8.4%)113 (8.5%)Active SmokingP = 0.70948.3%47.7%LVEF \< 50%0.44198 (8%)94 (7%)Valve surgeryNS17.8%16.5%INYHA5.3%5.9%II3.2%5.2%IIIA0.9%1.2%IIIB0.2%0.1%IVLaboratory values0.146970eGFR ml/min/1.73 m^2^NS13.113.56Hb (gr/dL)MedicationsP = 0.30978.5%76%ARB or ACE-IP = 0.54870.3%69.5%Beta Blockers0.01185%88%Statins0.1382%86%Platelet inhibitorsP = 0.3035.7%6.4%DigitalisStress test parameters\<0.0017.736.86METS value\<0.00107:4406:41Test duration (min:sec)0.0170 ± 1372 ± 13Resting heart rate (BPM)0.01124 ± 19126 ± 24Resting SBP (mmHg)\<0.00154 ± 2449 ± 24Heart rate reserve (BPM)0.44161 ± 27164 ± 94Max SBP (mmHg)[^3]

Patients with lower ALT activity levels at the initiation of rehabilitation program had lower estimated METs values (6.86 vs. 7.73; p \< 0.001), shorter stress test duration (06:41 vs. 07:44 min; p \< 0.001), higher resting heart rate (72 ± 13 vs. 70 ± 13 BPM; p = 0.01) and lower heart rate reserve (49 ± 24 vs. 54 ± 24; p \< 0.001) ([Table 1](#tbl1){ref-type="table"}).

Within our study population, patient characteristics that were found to be independently predictable of lower ALT blood activity were: age (OR = 1.02; 95%CI 1.01--1.03; P \< 0.001); female gender (OR = 1.87; 95%CI 1.60--2.20; P \< 0.001), and increased blood creatinine concentration (OR = 1.44; 95%CI 1.08--1.92; P = 0.01) ([Table 2](#tbl2){ref-type="table"}).Table 2Patient characteristics found to be independent predictors for lower ALT activity.Table 2P value95%CIORCovariateUpperLower\<0.0012.201.601.87Female gender0.041.391.011.19Diabetes mellitus\<0.0011.581.121.33Past CABG0.151.300.961.12Hypertension0.020.970.720.83Dyslipidemia0.681.350.821.05Smoker0.221.420.921.15Past Valve surgery0.111.060.590.79Cardiomyopathy0.002.411.211.70COPD0.701.170.790.96Atrial Fibrillation or flutter0.031.611.021.29Past CVA0.041.751.021.33LVEF \<50%0.0761.000.940.97BMI0.011.921.081.44Blood Creatinine concentration (per 1 mg/dL increment)0.040.990.570.75Past MI\<0.0011.031.011.02Age (per year increment)

Correlation of lower ALT values with reduced exercise capacity {#sec3.1}
--------------------------------------------------------------

Multivariate linear modeling demonstrated that ALT values were Independent determinants of baseline exercise capacity (expressed in METs) ([Table 3](#tbl3){ref-type="table"}). With relation to a cutoff value of 17 IU/L, found to be significant in previous studies,[@bib10], [@bib12] we found that low ALT activity, as a categorical parameter (below or above 17IU/L) was also significantly associated with low baseline exercise capacity. Additional significant predictors were age, hemoglobin, lower LVEF, diagnosis of COPD or heart failure.Table 3A multivariate linear model for independent determinants of baseline exercise capacity (expressed in METs).Table 3p valueCoefficientCovariate\<0.0010.024ALT (IU/dl)[a](#tbl3fna){ref-type="table-fn"}\<0.001−0.117Age[a](#tbl3fna){ref-type="table-fn"}\<0.0011.86Heart failure diagnosis\<0.0010.204Hemoglobin g/dL[a](#tbl3fna){ref-type="table-fn"}\<0.0010.024LVEF %[a](#tbl3fna){ref-type="table-fn"}\<0.0011.202COPD diagnosis[^4]

Discussion {#sec4}
==========

The aim of this study was to examine the association of low ALT, an independent marker of frailty, with the baseline exercise capacity of participants of a cardiac rehabilitation program. In this cohort, low ALT activity was associated with unfavorable baseline physical parameters in comparison with the general study population. These finding correlate well with previous studies that showed the association between low ALT activity and worse clinical outcomes, in variable patients\' populations.[@bib9], [@bib10], [@bib11], [@bib12] In our cohort, low ALT activity was associated with lower estimated METs values, higher resting heart rate and shorter stress test duration. We showed, in a multi-variate model, that low ALT serves as an independent predictor for low baseline exercise capacity, independent from other physiologic variables that share this prognostic value by themselves (including blood hemoglobin concentration and left-ventricular heart failure parameters). These findings raise the possibility that such patient populations might have lower rehabilitation potential, although further research is needed. The recognition of the frail patient itself and the markers of frailty before the initiation of cardiac rehabilitation program are imperative due to the need for better prognostication and for viewing the anticipated rehabilitation results. In light of our findings, it might be reasonable to suggest that ALT may be used, among other criteria, to identify a specific sub-population of frail patients requiring cardiac rehabilitation. The implication may be that these patients will require a specialized rehabilitation programs that will be suitable for their unique needs. This study did not address the question regarding the potential changes in ALT levels post-exercise. It is plausible to assume, that measurements of ALT levels would reflect exercise programs\' impact on frailty and muscle mass. Such measurements, however, should not be made in close relation to intense exercise, after which increased ALT levels could potentially be associated with rhabdomyolysis.

Limitations {#sec4.1}
-----------

This was a retrospective study, and therefore, causality could not be inferred and the results are associated with statistically significant correlations only. Also, no conclusions can be drawn regarding rehabilitation programs differing from the standard cardiac protocols employed (e.g. anaerobic exercise).

Appendix A. Supplementary data {#appsec1}
==============================

The following is the supplementary data related to this article:mmc1mmc1

Supplementary data related to this article can be found at [https://doi.org/10.1016/j.jesf.2017.11.002](10.1016/j.jesf.2017.11.002){#intref0010}.
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[^3]: COPD, Chronic Obstructive Pulmonary Disease; IHD, Ischemic Heart Disease; CHF, Congestive Heart Failure; NS, Non-Significant; PVD, Peripheral Vascular Disease; NYHA, New York Heart Association functional status; ACE-I, Angiotensin Converting Enzyme Inhibitors; ARB, Angiotensin Receptor blockers; LVEF, Left Ventricle Ejection Fraction; BPM, Beats Per Minute; SBP, Systolic Blood Pressure.

[^4]: Introduced as continuous variables.
